Towards a unifying hypothesis for the pathogenesis of peripartum cardiomyopathy

International Journal of Cardiology

Volumn 153, Issue 1, 2011, Pages 1-3

  Fett, James D ^a,b   McTiernan, Charles F ^a,b  

^a North American Peripartum Cardiomyopathy Network   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Heart failure; Immune system; Pathogenesis; Peripartum cardiomyopathy; PPCM; Pregnancy

Indexed keywords

BROMOCRIPTINE; C REACTIVE PROTEIN; FAS ANTIGEN; GAMMA INTERFERON; HEART ANTIBODY; INTERLEUKIN 6; PROLACTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EDITORIAL; EVIDENCE BASED MEDICINE; HEART MUSCLE BIOPSY; HEART PERFUSION; HUMAN; IMMUNOPATHOGENESIS; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PERIPARTUM CARDIOMYOPATHY; PREGNANCY; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK ASSESSMENT; RISK FACTOR; TH1 TH2 BALANCE; UNSPECIFIED SIDE EFFECT; VIRUS PATHOGENESIS;

CARDIOMYOPATHIES; FEMALE; HUMANS; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 81055140367     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.09.001     Document Type: Editorial

References (67)

1. U. Elkayam Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management J Am Coll Cardiol 58 Aug 9 2011 659 667
2. E.P. Gunderson, L.A. Croen, V. Chiang, C.K. Yoshida, D. Walton, and A.S. Go Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes Obstet Gynecol 118 3 Sep 2011 583 591
3. S.J. Whitehead, C.J. Berg, and J. Chang Prenancy-related mortality due to cardiomyopathy: United States, 1991-1997 Obstet Gynecol 102 2003 1326 1331
4. C. Deneux-Tharaux, C. Berg, and M.H. Bouvier-Colle Underreporting of pregnancy-related mortality in the United States and Europe Obstet Gynecol 106 2005 684 692
5. B. Gouley, T. McMillan, and S. Bellet Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium Am J Med Sci 19 1937 185 199
6. J.B. O'connell, M.R. Costanzo-Nordin, and R. Subramanian Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics JACC 8 1986 52 56
7. J. Marmursztejn, O. Vignaux, F. Goffinet, L. Cabanes, and D. Duboc Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy Int J Cardiol 137 3 Nov 12 2009 e63 e64 Epub 2009 May 12
8. J.D. Fett The role of MRI in peripartum cardiomyopathy Int J Cardiol 137 2009 185 186
9. L.T. Cooper Medical progress: myocarditis N Engl J Med 360 2009 1526 1538
10. D.M. Renz, R. Tottgen, and D. Habedank New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging Rofo Aug 9 2011 [Epub ahead of print]
11. V. Fuster The AHA guidelines and scientific statements handbook 2009 American Heart Association. Wiley-Blackwell Pub UK
12. K. Sliwa, D. Skudicky, A. Bergemann, G. Candy, A. Puren, and P. Sareli Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1 J Am Coll Cardiol 35 2000 701 705
13. A.A. Ansari, J.D. Fett, R.D. Caraway, A.E. Mayne, M. Onlamoon, and J.B. Sundstrom Autoimmune mechanisms as the basis for human peripartum cardiomyopathy Clin Rev Allergy Immunol 23 2002 301 324
14. Y. Furukawa, K. Kobuke, and A. Matsumori Role of cytokines in autoimmune myocarditis and cardiomyopathy Autoimmunity 34 2001 165 168
15. K. Sliwa, D. Skudicky, G. Candy, A. Bergemann, M. Hopley, and P. Sareli The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy Eur J Heart Fail 4 2002 305 309
16. J.E. Ellis, A.A. Ansari, and J.D. Fett Inhibition of progenitor dendritic cell maturation by plasma from patients with peripartum cardiomyopathy: role in pregnancy-associated heart disease Clin Dev Immunol 12 2005 265 273
17. E. Lindberg, Y. Magnusson, K. Karason, and B. Andersson Lower levels of the host protective IL-10 in DCM-a feature of autoimmune pathogenesis? Autoimmunity 41 2008 478 483
18. R. Sheppard, M. Bedi, and T. Kubota Myocardial expression of fast and recovery of left ventricular function in patients with recent-onset cardiomyopathy J Am Coll Cardiol 46 2005 1036 1042
19. J.D. Fett, and A.A. Ansari Inflammatory markers and cytokines in peripartum cardiomyopathy: a delicate balance Expert Opin Ther Target 14 10 2010 1 4 Epub ahead of print 8-1-2010
20. K. Sliwa, O. Forster, and E. Libhaber Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients Eur Heart J 27 2006 441 446
21. M. Platten, S. Youssef, and E.M. Hur Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1 and TH17-mediated autoimmunity Proc Natl Acad Sci U S A Aug 19 2009 [Epub ahead of print]
22. J.D. Fett, J.B. Sundstrom, and A.A. Ansari Evidence that plasma C-reactive protein may provide diagnostic help in peripartum cardiomyopathy (oral abstract, American Heart Association Annual Scientific Session; 2007) Circulation 116 Suppl II-422 1959
23. M. Satoh, M. Nakamura, T. Akatsu, Y. Shimoda, I. Segawa, and K. Hiramori C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy Eur J Heart Fail 7 2005 748 754
24. K. Kaneko, T. Kanda, A. Hasegawa, T. Suzuki, I. Kobayashi, and R. Nagai C-reactive protein as a prognostic marker in lymphocytic myocarditis Jpn Heart J 41 2000 41 47
25. D.A. Somerset, Y. Zheng, M.D. Kilby, D.M. Sansom, and M.T. Drayson Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset Immunology 112 2004 38 43
26. I.J. Elenkov, R.L. Wilder, and V.K. Bakalov IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times J Clin Endocrinol Metab 86 2001 4933 4938
27. M. Watanabe, Y. Iwatani, and T. Kaneda Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy Am J Reprod Immunol 37 1997 368 377
28. T.F. Davies The thyroid immunology of the postpartum period Thyroid 9 1999 675 684
29. G. Ruiz-Irastorza, F. Lima, and J. Alves Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies Br J Rheumatol 35 1996 133 138
30. P.K. Rabiah, and A.T. Vitale Noninfectious uveitis and pregnancy Am J Ophthalmol 136 2003 91 98
31. R.S. Warraich, J.D. Fett, and A. Damasceno Impact of Pregnancy related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulinss in peripartum Cardiomyopathy Am Heart J 150 2005 263 269
32. I.C. Chikanza, P. Petrou, G. Chrousos, G. Kingsley, and G.S. Panayi Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications Br J Rheumatol 32 1993 445 448
33. F.E. Figueroa, F. Carrion, M.E. Martinez, S. Rivero, and I. Mamani Bromocriptine induces immunological changes related to disease parameters in rheumatoid arthritis Br J Rheumatol 36 1997 1022 1023
34. E.W. Bernton, M.S. Metzler, and J.W. Holaday Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice Science 239 1988 401 404
35. Yu-Lee Ly Molecular actions of prolactin in the immune system Proc Soc Exp Biol Med 215 1997 35 52
36. R.W. McMurray, D. Weidensaul, S.H. Allen, and S.E. Walker Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus J Rheumatol 22 1995 2084 2091
37. M.A. Gutierrez, J.F. Molina, and L.J. Jara Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity Lupus 4 1995 348 352
38. D. Hilfiker-Kleiner, K. Kaminski, and E. Podewski A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy Cell 128 2007 589 600
39. A. Leanos-Miranda, J. Marquez-Acosta, and G.M. Cardenas-Mondragon Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes J Clin Endocrinol Metab 93 2008 2492 2499
40. K. Sliwa, L. Blauwet, and K. Tibazarwa Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy. A proof-of-concept pilot study Circulation 121 2010 1465 1473
41. T. Hung, L. Lo, and T. Chiu A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation Reprod Sci 17 2010 401 409
42. P. Kaushik, S.R. Vatsavai, V.R. Banda, Pramod K. Sanghi, M. Ahmad, and R. Kaushik Acute onset of severe dilated cardiomyopathy during bromocriptine therapy Ann Pharmacother 38 2004 1219 1221
43. J.D. Fett Caution in the use of bromocriptine in peripartum cardiomyopathy J Am Coll Cardiol 51 2008 2083
44. G. Ambrosini, K. Nanhornbque, I. Pascoli, M. Cester, and E. Cosmi Mirror syndrome due to Coxsackie B virus associated to maternal peripartum cardiomyopathy J Perinat Med 36 2008 453 454
45. B.D. Bultmann, K. Klingel, M. Nabauer, D. Wallwiener, and R. Kandolf High prevalence of viral genomes and inflammation in peripartum cardiomyopathy Am J Obstet Gynecol 193 2005 363 365
46. T. Muroya, S. Ikeda, and T. Yamasa High dose immune globulin therapy ameliorates peripartum cardiomyopathy with elevated serum antibody titer to influenza virus: case report of two patients Med Sci Monit 16 2 Feb 2010 CS11 CS14
47. U. Kuhl, M. Pauschinger, and P.L. Schwimmbeck Interferon-B treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction Circulation 107 2003 2793 2800
48. S. Fujioka, Y. Kitaura, and H. Deguchi Evidence of viral infection in the myocardium of American and Japanese patients with idiopathic dilated cardiomyopathy Am J Cardiol 94 2004 602 605
49. H. Zhang, Y. Li, and D.R. McClean Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes Med Microbiol Immunol (Berl) 193 2004 109 114 [Electronic publication ahead of print 2003 Nov 22]
50. D. Fairweather, S. Yusung, and S. Frisancho IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication J Immunol 170 2003 4731 4737
51. U. Kuhl, M. Pauschinger, and B. Seeberg Viral persistence in the myocardium is associated with progressive cardiac dysfunction Circulation 112 2005 1965 1970 [Electronic publication ahead of print 2005 Sept 19]
52. F. Kuethe, H.H. Sigusch, and K. Hilbig Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy Am Heart J 153 5 2007 850 858
53. S.A. Huber Chapter 3 L.T. Cooper, Myocarditis: from bench to bedside 2003 Humana Press Totowa, NJ 68
54. A. Muscaro-Blanco, K. Alvarez, and X. Yu Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies Autoimmunity 41 2008 442 453
55. S.L. Hill, and N.R. Rose The transition from viral to autoimmune myocarditis Autoimmunity 34 2001 169 176
56. R. Jahns, V. Boivin, and L. Hein Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy J Clin Invest 113 2004 1419 1429
57. N.J. Freedmann, and R.J. Lefkowitz Anti-B1-adrenergic receptor antibodies and heart failure: causation, not just correlation J Clin Invest 113 2004 1379 1382
58. B. Maisch, D. Arsen, and D. Ristic Chapter 4: Humoral immune response in viral myocarditis L.T. Cooper, MYOCARDITIS; from bench to bedside 2003 Humana Press Totowa, NJ
59. Y. Li, J.S. Heuser, L.C. Cunningham, S.D. Kosanke, and M.W. Cunningham Mimicry and antibody-mediated cell signaling in autoimmune myocarditis J Immunol 177 2006 Dec 8234 8244
60. L.T. Cooper, R. Virmani, and N.M. Chapman National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathy Mayo Clin Proc 81 2006 99 204
61. J.D. Fett, J.B. Sundstrom, M.E. King, and A.A. Ansari Mother-daughter peripartum cardiomyopathy Int J Cardiol 86 2002 331 332
62. J.A. Pierce Familial occurrence of postpartal heart failure Arch Intern Med 111 1962 163 166
63. B.D. Horne, K.D. Rasmusson, and R. Alharethhi Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy Circ Cardiovasc Genet June 10 2011 [Epub ahead of print]
64. S.S. Brar, S.S. Khan, and G.K. Sandhu Incidence, mortality, and racial differences in peripartum cardiomyopathy Am J Cardiol 100 2007 302 304
65. J.D. Fett, L.G. Christie, R.D. Carraway, and J.G. Murphy Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution Mayo Clin Proc 80 2005 1602 1606
66. J.D. Fett, A.A. Ansari, J.B. Sundstrom, and G.R. Combs Jr. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection Int J Cardiol 86 2002 311 316
67. Investigations in Pregnancy Associated Cardiomyopathy (IPAC) Available at: http://www.peripartumcmnetwork.pitt.ed